Top Markets
#1 Black Phoenix Black Phoenix +356.02%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.09%
#4 Akedo Akedo +49.04%
#5 Acurast Acurast +34.81%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.91%
#7 BasedHype BasedHype +25.95%
#8 Avantis Avantis +23.73%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
주식 순위 #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
주가
$0.0202
마지막 동기화: 2024-11-19
시가총액
$44.67K
변동 (1일)
-0.49%
변동 (1년)
0.00%
국가
IL
거래 Notable Labs, Ltd. (NTBL)

카테고리

Healthcare
Notable Labs, Ltd. (NTBL)의 매출
Jun 2024 기준 매출 TTM: $3.00K
Notable Labs, Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $3.00K입니다. 2022년에 회사는 $8.00K의 수익을 올렸으며 이는 2021년의 $285.00K 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Notable Labs, Ltd.의 수익 기록 (2015 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $3.00K -99.03%
2023 $310.00K 3,775.00%
2022 $8.00K -97.19%
2021 $285.00K -69.09%
2020 $922.00K 64.06%
2019 $562.00K -3.93%
2018 $585.00K -95.78%
2017 $13.86M 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 420,809,900.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 200,709,476.97%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 337,026,123.20%
BE